Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 13:7:612773.
doi: 10.3389/fnut.2020.612773. eCollection 2020.

Gut Microbiota and Type 1 Diabetes Mellitus: The Effect of Mediterranean Diet

Affiliations
Review

Gut Microbiota and Type 1 Diabetes Mellitus: The Effect of Mediterranean Diet

Cinzia Myriam Calabrese et al. Front Nutr. .

Abstract

Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease resulting from a complex interplay between genetic susceptibility and environmental factors. Regarding the latter, gut microbiota has a pivotal role in the pathogenesis of T1DM, by affecting intestinal permeability, molecular mimicry, and modulating innate and adaptive immune system, as described in several previous studies. The composition of the gut microbiota is largely influenced by diet. Some observational studies have shown that a low fiber intake is associated with the development of many inflammatory and immune-mediated diseases. In this context, the Mediterranean diet (MD), which is based on high consumption of cereals (preferably as whole grains), legumes, nuts, vegetables, fruits, olive oil, and fish, could play a protective role. Many of the characteristic components of MD have functional characteristics with positive effects on health and well-being. Eating habits are the main significant determinants of the microbial multiplicity of the intestine and the food components influence both microbial populations and their metabolic activities from the early stages of life. Moreover, food metabolites influence the immune response. The intestine is considered the primary site where food metabolites mediate their effects, through epithelial integrity or mucosal immunity. The compromised epithelial integrity allows the translocation of bacteria and/or the diffusion of their products, such as food antigens and lipopolysaccharides, from the intestinal lumen to the tissues, which could enhance the stimulation of immune cells, contributing to the pathogenesis of autoimmune diseases, such as T1DM. The intake of a high amount of fiber and therefore of prebiotics with MD allows the microbiota to have a good microbial balance. Moreover, as more dietary fibers are ingested, a higher amount of short-chain fatty acids (SCFAs) is produced by anaerobic gut microbiota, promoting gut homeostasis, to which also contribute tryptophan metabolites and omega-3-fatty acids. Furthermore, the higher intake of polyunsaturated fatty acids and omega-3-fatty-acids contribute to a better metabolic control. In this review we report the relationship between gut microbiota and T1DM and we explore the effects of Mediterranean diet on microbiota as a potential therapeutic strategy, aimed at preventing or delaying progression of T1DM and its complications.

Keywords: Mediterranean diet; fibers; gut microbiota; short-chain fatty acids; type 1 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Mediterranean diet (MD) induces changes in gut microbiota by promoting the growing of taxa which contribute to a greater formation of short-chai fatty acids (SCFAs) and to a lower production of trimethylamine N-oxide (TMAO), leading to a delay in the progression of type 1 diabetes mellitus (T1DM) and in the development of cardiovascular complications.

References

    1. American Diabetes Association . Classification and diagnosis of diabetes: standards of medical care in diabetes −2020. Diabetes Care. (2020) 43 (Suppl. 1):S14–31. 10.2337/dc20-S002 - DOI - PubMed
    1. Ilonen J, Lempainen J, Veijola R. The heterogeneous pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol. (2019) 15:635–50. 10.1038/s41574-019-0254-y - DOI - PubMed
    1. Di Meglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. (2018) 391:2449–62. 10.1016/S0140-6736(18)31320-5 - DOI - PMC - PubMed
    1. Acharjee S, Ghosh B, Al-Dhubiab BE, Nair AB. Understanding type 1 diabetes: etiology and models. Can J Diabetes. (2013) 37:269–76. 10.1016/j.jcjd.2013.05.001 - DOI - PubMed
    1. Ounissi-Benkalha H, Polychronakos C. The molecular genetics of type 1 diabetes: new genes and emerging mechanisms. Trends Mol Med. (2008) 14:268–75. 10.1016/j.molmed.2008.04.002 - DOI - PubMed

LinkOut - more resources